Vaxcyte, Inc. (PCVX) NASDAQ
60.88
-0.81(-1.31%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
60.88
-0.81(-1.31%)
Currency In USD
| Market Cap | 6.28B |
| Enterprise Value | 6.33B |
| P/E Ratio | -10.81 |
| PEG Ratio | 0.77 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.09 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -11.28 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.25 |
| Return On Equity | -0.26 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -741.77M |
| Net Income | -766.63M |
| Diluted EPS | -5.63 |
| Total Cash | 1.56B |
| Total Cash/Share | 11.47 |
| Total Debt | 228.84M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 7.91 |
| Book Value Per Share | 19.73 |
| 52-Week Change | 90.01 |
| 52-Week High | 65 |
| 52-Week Low | 28.09 |
| Moving Average 50 Days | 57.17 |
| Moving Average 200 Days | 44.23 |
| Average Volume | 1.43M |
| Shares Outstanding | 143.92M |
| % Held by Institutions | 108.35 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |